Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Xencor's XmAb5871 Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease

americanpharmaceuticalreviewMay 12, 2017

Tag: Orphan Drug , Xencor

PharmaSources Customer Service